TAG ARCHIVE

POSTS TAGGED AS glioblastoma

Attacking Brain Tumors with Liquid Polymer Nanoparticles

September 20, 2022 | | Posted in Newsletter

Nanomedicine opens door to precision medicine for brain tumors
In an example of “customized nanomedicine,” cancer researchers at Northwestern University constructed [MORE]

Photoimmunotherapy for Brain Cancer

August 30, 2022 | | Posted in Newsletter

Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
“PIT [photoimmunotherapy] is a light-mediated therapeutic approach, where a photosensitiser (PS) is conjugated to [MORE]

Mimicking the Tumor Microenvironment with a Lab 3D Printed Glioblastoma

November 2, 2021 | | Posted in Newsletter

3D Bioprinting of entire active glioblastoma
To construct better models of tumor tissue, researchers at Tel Aviv University “. . .  [MORE]

Glioblastoma Nanomedicine

January 26, 2021 | | Posted in Newsletter

Glioblastoma nanomedicine crosses iBBB in mice
“Inspired by the capacity of natural proteins and viral particulates to cross the BBB, we [MORE]

Spherical Nucleic Acids for Immunotherapy

July 2, 2019 | | Posted in Newsletter

Spherical nucleic acid
“Researchers from Northwestern University have leveraged machine learning to aid in the design of nanomedicines for immunotherapy. They [MORE]

Georgetown’s REMBRANT

October 9, 2018 | | Posted in Newsletter

Bioinformatics
REMBRANT is an acronym for Repository for Molecular Brain Neoplasms Data.  Originally, the National Cancer Institute compiled and organized the [MORE]

Attacking Brain Tumors with Liquid Polymer Nanoparticles

September 19, 2017 | | Posted in Newsletter

Glioblastoma Cells
In an example of “customized nanomedicine,” cancer researchers at Northwestern University constructed lipid nanoparticles carrying four siRNAs aimed at [MORE]

Pulsing Device to Treat Glioblastomas

December 22, 2015 | | Posted in Newsletter

Optune
Pulsed electric field technology, directed to disrupt cytoskeleton features of tumor cells, particularly glioblastomas, may be a way to treat [MORE]

iRNA Therapy for Glioblastoma

April 28, 2015 | | Posted in Newsletter

Glioblastoma
Glioblastoma multiforma is one of the deadliest forms of cancer. And, it has proven tenaciously resistant to every form of [MORE]

A Blood Test for Glioblastoma

January 13, 2015 | | Posted in Newsletter

HealthTell Molecular Diagnostics
Using peptide arrays, HealthTell (San Ramon, CA) is testing their product which supposedly offers early, accurate and noninvasive [MORE]